Radar · Healthcare in Shanghai
Best Healthcare Companies in Shanghai, China
The 236 best Healthcare companies in Shanghai, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: MediTrust Health.
By Rohit KhannaTrends & Stories
236companies tracked
$5.5Bdisclosed funding
0unicorns
91have raised
Ranked: Best Healthcare companies in Shanghai
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MediTrust Health Provider of medical payment services | $463M | 41 mo ago | 132 | 2017 | Seth Zhang Co-Founder & CEO | — | — | — |
| 2 | CStone Pharma Developing and licensing novel drugs for diseases including cancer and autoimmune diseases | $410M | 68 mo ago | 476 | 2016 | — | — | — | 1 partnership |
| 3 | Shanghai Henlius Biotech Biotech arm of Fosun with a focus of Monoclonal Antibodies | $347M | 95 mo ago | 3,602 | 2010 | — | Microsoft ASP.NETBootstrapTengine+2 | 283 patents Immuno‑oncology biologics and antibody‑drug conjugates targeting PD‑1/PD‑L1 and OX40. | 1 partnership |
| 4 | Mabwell R & D company focused on manufacturing of pharmaceutical products for multiple therapeutic products | $278M | 73 mo ago | 1,451 | 2017 | Datao Liu Co-Founder | PHPUbuntuApache HTTP Server+3 | — | — |
| 5 | Abbisko Therapeutics Developing novel small molecule drugs for immunomodulatory pathways to treat cancer | $263M | 65 mo ago | 252 | 2016 | — | — | 309 patents Small-molecule kinase inhibitor drugs targeting FGFR4, CSF‑1R, CDK, CD73, PARP for cancer therapy | — |
| 6 | Shanghai Kehua Bio-engineering Developers, manufacturers and marketers of in vitro diagnostic products | $262M | 148 mo ago | 2,709 | 1998 | — | Windows ServerAnimate.cssMicrosoft ASP.NET+5 | — | 2 launchs · 1 partnership |
| 7 | ZGBiotech CDMO focused on drug development, analytical, formulation, and quality testing services 72Funding top 24%Market top 28%Global bottom 38% All 3 signals ▾Fundingtop 24% Markettop 28% Globalbottom 38% Funding: Raised $240M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) Market: 600 employees (top 9% of Industrial Goods and Manufacturing) rank vs industry peers · Fliar Intelligence Index 72/100 | $240M | 46 mo ago | 600 | 2017 | — | — | — | — |
| 8 | Genor Biopharma Developer of biosimilar monoclonal antibodies for treating multiple diseases | $216M | 72 mo ago | 222 | 2007 | — | — | 45 patents Bispecific/trispecific immune‑checkpoint antibodies for cancer immunotherapy | — |
| 9 | Shanghai Cell Therapy Group Provider of cell-therapy focused research and development services | $202M | 62 mo ago | 70 | 2014 | — | PHPLayuiTengine+3 | — | — |
| 10 | Viva Biotech Research services focused on drug discovery and development | $180M | 36 mo ago | 2,271 | 2006 | — | PHPNginxSwiper+7 | — | — |
| 11 | Allist Pharmaceutical Technology Developer of small molecules for cancer and diabetic treatment | $171M | 84 mo ago | 870 | 2004 | — | — | — | — |
| 12 | Luye Pharma Developer of innovative pharmaceutical products and treatments | $161M | 64 mo ago | 1 | 1994 | — | BootstrapSwiperjQuery+2 | — | — |
| 13 | VelaVigo Biotechnology research company developing biological drugs | $160M | 10 mo ago | — | 2021 | Tong Zhang Co-Founder | — | — | 1 job opening |
| 14 | Shanghai Pharmaceuticals Holding Integrated pharmaceutical production and distribution company | $160M | 63 mo ago | 42,236 | 1994 | Man Cho CEO & President | BootstrapHandlebarsjQuery+1 | 231 patents Design and synthesis of nitrogen‑heterocyclic pharmaceuticals and immunotherapy CAR‑T agents | — |
| 15 | Arctic Vision Limited information available | $132M | 63 mo ago | 50 | 2019 | Eddy Wu Founder & CEO | — | — | — |
| 16 | DeltaHealth Chain of multispecialty hospitals | $100M | 57 mo ago | — | 2012 | Norman Chen Co-Founder | — | — | 1 award |
| 17 | Dizal Pharma Limited information available | $100M | 69 mo ago | 328 | 2017 | — | — | — | — |
| 18 | Tongshu Biotechnology Research lab focused on gene sequencing technology and biological information analysis | $92M | 20 mo ago | 1 | 2016 | Yan Linghua CEO | — | — | — |
| 19 | OBiO Technology CDMO focused on providing services for cell & gene therapy products | $88M | 68 mo ago | — | 2013 | Oudong Pan Founder | CodeMirrorTinyMCEPHP+13 | — | — |
| 20 | UVCLINIC Chain of radiology labs | $86M | 76 mo ago | 6 | 2015 | Yang Huanqian CEO | PHPWindows ServerPlyr+12 | — | — |
| 21 | Mojia Biotech Developer of biomanufacturing solutions for chemical materials and agricultural additives 42Moat top 22%Funding top 31%AI top 45%Talent bottom 49% All 7 signals ▾Moattop 22% Fundingtop 31% AItop 45% Talentbottom 49% Marketbottom 37% Globalbottom 36% Newsbottom 22% Moat: Editorial + unicorn rating 8/10 · Soonicorn Funding: Raised $80.0M across 1 rounds · 1 rounds over 4 yrs (0.2/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $80M | 47 mo ago | — | 2017 | Indra Santana CEO | — | — | — |
| 22 | Hygeia Medical Manufacturer of medical disposable products | $77M | 61 mo ago | 6,659 | 2003 | — | — | — | — |
| 23 | Zion Pharma Manufacturer of anticancer focused drugs | $75M | 58 mo ago | 15 | 2018 | Ding Zhou Founder | — | — | — |
| 24 | Shanghai Hanyu Medical Technology Manufacturer of cardiac medical devices | $72M | 63 mo ago | 91 | 2016 | — | — | — | — |
| 25 | Excalipoint Biotechnology company developing next-generation T-cell engager platforms for cancer and autoimmune diseases | $69M | 3 mo ago | — | 2025 | Jielun Zhu Co-Founder & CFO & CBO | — | — | — |
| 26 | Sinopharm Online Pharmaceutical e-commerce platform | $62M | 85 mo ago | — | 2015 | Wang Letian CEO | — | — | — |
| 27 | Fountain Medical Development Full-service CRO based out of China and East Asia | $62M | 79 mo ago | 66 | 1995 | Ling Zhen CEO & Co-Chairman | — | — | — |
| 28 | InCarey Retailer of medicines, health products, and medical equipment | $61M | 53 mo ago | 300 | 2011 | — | — | — | — |
| 29 | Kedu Medical Technology Provider of medical device maintenance and management services for healthcare providers | $60M | 78 mo ago | 1,500 | 2006 | — | — | — | — |
| 30 | Eddingpharm Provider of biopharmaceutical products for critical illnesses | $56M | 103 mo ago | 1,314 | 2001 | — | Animate.cssMicrosoft ASP.NETTengine+4 | — | — |
| 31 | Yueer Gene R&D company manufacturing diagnostic products | $50M | 48 mo ago | — | 2016 | Zhang Yu Co-Founder | — | — | — |
| 32 | Yaoyanshe APP focused on pharmaceutical research | $43M | 70 mo ago | 58 | 2012 | — | — | — | — |
| 33 | Methuselah Medical Technology Supplier and manufacturer of medical nutrition products | $41M | 10 mo ago | 68 | 2012 | — | — | — | — |
| 34 | Eccogene CRO focused on development of drugs for metabolic and immune-related diseases | $40M | 36 mo ago | — | 2018 | Jingye Zhou Co-Founder & CEO | — | 3 patents SSAO enzyme inhibitors—heterocyclic small‑molecule pharmaceuticals targeting amine oxidase activity | — |
| 35 | WuXi AppTec Provider of CRO and CDMO services | $40M | 62 mo ago | 1,681 | 2000 | — | WordPressMySQLRedis+29 | 20 patents Drug discovery platforms and small‑molecule/biologic modulators for immune and ion channels | — |
| 36 | Ezisurg Medical Manufacturer of surgical medical devices | $36M | 69 mo ago | 500 | 2011 | Henry Nie Founder & CEO | PHPNginxMicrosoft Clarity+5 | 91 patents Surgical stapling and ultrasonic cutting instruments with bendable actuation mechanisms. | 1 expansion |
| 37 | Shanghai Donglei Brain Hospital Standalone multispecialty hospital | $31M | 54 mo ago | 14 | 2016 | Song Donglei Founder | — | — | — |
| 38 | Zezheng Pharmaceutical R&D company manufacturing drugs for multiple therapeutic areas | $31M | 53 mo ago | — | 2021 | He Dunwei CEO | — | — | — |
| 39 | Shanghai Bocimed Pharmaceutical Developer and manufacturer of APIs and intermediates | $29M | 40 mo ago | 200 | 2007 | — | — | — | — |
| 40 | ChemLex Provider of consulting services in the field of chemical research and development through artificial… | $26M | 6 mo ago | — | — | Sean Lin Founder & CEO | BootstrapGSAPAmazon Web Services+5 | — | — |
| 41 | Forerunnermed Defveloper of surgical electrode implants and radio-frequency systems | $24M | 63 mo ago | 23 | 2009 | — | — | — | — |
| 42 | JoyMed Technology Provider of contract development and manufacturing services for medical devices | $20M | 44 mo ago | 90 | 2014 | — | — | — | — |
| 43 | Shanghai Yaocheng Health Technology Provider of clinical trial services to biopharma sector | $15M | 44 mo ago | 100 | 2020 | Xu Pengcheng Co-Founder & CEO | — | — | — |
| 44 | Lepure Biotech Provider of traditional packaging, dispensing, and storage solutions | $15M | 41 mo ago | — | 2011 | Wang Fengfrank CEO | — | — | — |
| 45 | Yinjia Biotech Provider of protein reagents, kits, and related products for biopharmaceutical applications | $15M | 41 mo ago | — | 2020 | Wu Yifei Founder & CEO | — | — | — |
| 46 | UP Clinic Orthopedic rehabilitation centers | $15M | 54 mo ago | 60 | 2018 | — | — | — | — |
| 47 | Fu Shou Kang (Shanghai) Medical Elderly Service Chain of rehabilitation and long-term care centers | $14M | 41 mo ago | 10,000 | 2011 | Zhang Jun Founder & CEO | — | — | — |
| 48 | Bosten Health Provider of data analysis and technology services for healthcare management services | $14M | 42 mo ago | — | 2016 | Lu Xiaoxiang CEO | — | — | — |
| 49 | Shanghai Aipqiang Particle Equipment Provider of proton therapy systems and related particle equipment | $6M | 35 mo ago | 68 | 2012 | — | — | — | — |
| 50 | Travention R&D company focused on manufacturing medical devices for multiple therapeutic areas | $1M | 22 mo ago | — | 2021 | Shizhou Cai Founder & CEO | — | — | — |
Top 12 Healthcare companies in Shanghai
#1
Seed · Shanghai, Shanghai · founded 2025$68.7Mraised▾
Seed · Shanghai, Shanghai · founded 2025
Biotechnology company developing next-generation T-cell engager platforms for cancer and autoimmune diseases. The company aims to overcome tumor challenges in immunology and oncology.
Funding rounds
- Mar 2026Seed$68.7M
Founders & team
Investors
HSG, Apricot Capital, Yuanbio Venture Capital, 5Y Capital, Co-win Ventures, Medfine Capital
#2
Seed · Shanghai, Shanghai · founded 2021$160Mraised▾
Seed · Shanghai, Shanghai · founded 2021
Biotechnology research company developing biological drugs. It is a biopharmaceutical research company that develops biological drugs including bispecific and multi specific antibodies, ADC, and new modalities.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 737 LinkedIn followers
Hiring: 1 hiring post in 12 mo (public)
Funding rounds
- Jul 2025Seed$60M
- Dec 2024Seed$50M
- Nov 2021Angel$50M
Founders & team
Investors
Panacea Venture, Delian Capital, Everjoy Fortune, Lenovo, Shanghai Healthcare Capital, HLC
#3
Series B · Shanghai, Shanghai$26Mraised▾
Series B · Shanghai, Shanghai
ChemLex is a knowledge-based company that focuses on closed-loop collaborative research and development through artificial intelligence chemical synthesis path planning and high-throughput. They offer comprehensive consulting services in the field of chemical legislation and plant protection products.
Funding rounds
- Dec 2025Series B$45M
Founders & team
Investors
Qiming Venture Partners, LYFE Capital, Sinovation Ventures, MEGAROBO, Granite Asia
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesBootstrapGoogle AnalyticsGsap
#4
Series B · Shanghai, Shanghai · founded 2012 · 68 employees$41.4Mraised▾
Series B · Shanghai, Shanghai · founded 2012 · 68 employees
Supplier and manufacturer of medical nutrition products
Funding rounds
- Aug 2025Series B$13.9M
- Feb 2025Series B$27.5M
- Dec 2022Series A—
Investors
Frees Fund, CICC, Hudson Capital, Borchid Capital, HLC, 上海市商业投资（集团）有限公司
#5
Series D · Shanghai, Shanghai · founded 2016 · 1 employees$92.3Mraised▾
Series D · Shanghai, Shanghai · founded 2016 · 1 employees
Research lab focused on gene sequencing technology and biological information analysis
Funding rounds
- Oct 2024Series D$14.1M
- Jun 2021Series C$78.1M
- Sep 2020Series B—
- 2018Series A—
Founders & team
Investors
Langmafeng Venture Capital, Jiangsu Tuobang Environmental Protection Technology, Yuanbio Venture Capital, Fosun Health, Broad Vision Funds, Gl-investment
#6
Series C · Xuhui, Shanghai · founded 2017 · 132 employees$463Mraised▾
Series C · Xuhui, Shanghai · founded 2017 · 132 employees
MediTrust Health provides medical payment services. The company offers patients pharmaceutical finance, efficacy insurance, and pharmaceutical benefits. They offer complete patient financial staging services, comprehensive medication efficacy, safe drug supply and professional pharmacy services.
Funding rounds
- Jan 2023Series C—
- Aug 2021Series C$308.5M
- Mar 2021Series B$154.5M
- Mar 2020Series A—
Founders & team
Investors
China Life Reinsurance, Ant Group, NLVC, SAIF Partners, Sinovation Ventures, HSBC
#7
Public · Shanghai, Shanghai · founded 2006 · 2271 employees$180Mraised▾
Public · Shanghai, Shanghai · founded 2006 · 2271 employees
Viva is a multidisciplinary CRO with a focus on drug discovery and development. The company's services include Gene-to-protein and Gene-to-structure services, drug discovery with a focus on GPCR targets and antibody therapeutics discovery, fragment-based drug screening, medicinal chemistry, translational and in vivo pharmacology, in vitro pharmacology, DMPK and protein analysis, including crystallography services.
Funding rounds
- Jun 2023Post IPO—
- Jan 2020Post IPO$180M
- 2017Series A—
Investors
Temasek, Viva Ventures Biotech Fund, Shengshan Capital, Spinnotec, ShenZhen GTJA Investment Group
Tech stack
Baidu Analytics (百度统计)Google AnalyticsGoogle Tag ManagerHstsHubspotJquery
#8
Series C · Shanghai, Shanghai · founded 2017 · 600 employees$239.7Mraised▾
Series C · Shanghai, Shanghai · founded 2017 · 600 employees
CDMO focused on drug development, analytical, formulation, and quality testing services
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Funding
top 24%Market
top 28%Global
bottom 38%Funding: Raised $240M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) · Last round Series C (Aug 2022)
Market: 600 employees (top 9% of Industrial Goods and Manufacturing)
Global: Investors from 4 countries beyond China
Audience (LinkedIn): 1k LinkedIn followers — 2.5% of this cohort's audience
Funding rounds
- Aug 2022Series C$14.7M
- Jan 2022Series C$100M
- Mar 2021Series B$70M
- Mar 2020Series A$51M
Investors
LYFE Capital, IDG Capital, Cowin Capital, Junxin Capital, Jones Day, Korea Investment Partners
#9
Public · Shanghai, Shanghai · founded 2016 · 476 employees$410Mraised▾
Public · Shanghai, Shanghai · founded 2016 · 476 employees
CStone Pharma, a Shanghai-Suzhou startup, is developing and licensing novel drugs with a focus on immuno-oncology along with drugs for cardiovascular diseases, hematology and autoimmune diseases (e.g - rheumatoid arthritis). It has a robust oncology pipeline with eight assets in clinical stages. It is working on various targets including IDHm1, PDL-1, FGFR4, RET, PD-1, etc. The lead molecule, TIBSOVO has got FDA approval.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 16.1% of this cohort's audience
Activity: 1 partnerships (incl. Arrotex Pharmaceuticals) announced in 12 mo
Funding rounds
- Sep 2020Post IPO$200M
- May 2018Series B$260M
- Jul 2016Series A$150M
Investors
Oriza Ventures, Boyu Capital, 6 Dimensions Capital, Pfizer, GIC, Yunfeng Capital
#10
Public · Shanghai, Shanghai · founded 2016 · 252 employees$263Mraised▾
Public · Shanghai, Shanghai · founded 2016 · 252 employees
Abbisko therapeutics is developing novel small molecule drugs for immunomodulatory pathways to treat cancer. The company's pipeline has three preclinical candidates. The exact mechanism of action of each moleule has not been disclosed but the company is possibly advancing a STING/TLR activator, IDO/CSF1R inhibitor and TGF agonist. The company's integrated R&D center locates in the Shanghai Zhangjiang Hi-Tech Park. The company claims to be surrounded by numerous top CRO, CMO and clinical contract organizations in the area, with whom they collaborate o research in drug discovery and development. In the future, the company aims to target other diseases such as liver disease, viral infections and mental disease
Funding rounds
- Jan 2021Series D$123M
- Mar 2020Series C$70M
- Mar 2019Series B$42M
- Feb 2017Series A$28M
Investors
Lilly Asia Ventures, Temasek, GIC, Qiming Venture Partners, CICC, Loayal Valley Capital
#11
Series B · Pudong, Shanghai · founded 2018$40.5Mraised▾
Series B · Pudong, Shanghai · founded 2018
CRO focused on development of drugs for metabolic and immune-related diseases
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers — 2.1% of this cohort's audience
Funding rounds
- Jun 2023Series B$25.2M
- Mar 2021Series B—
- Dec 2020Series B$15.3M
Founders & team
Investors
Yuanhe Holdings, Chengyi Pharmaceutical, Sinopharm Capital, Huagai Capital, Delos Capital Partners, Qingsong Fund
#12
Series D · Shanghai, Shanghai · founded 2014 · 70 employees$201.9Mraised▾
Series D · Shanghai, Shanghai · founded 2014 · 70 employees
Provider of cell-therapy focused research and development services
Funding rounds
- Mar 2021Series D—
- Dec 2018Series C$135.7M
- Nov 2018Series C$39.6M
- 2016Series B$26.6M
Investors
China Asset Management, Legend Capital, Jiuzhou Venture Capital, CCB International, Haier Capital, Shanghai Shengshi Capital Management
Funding & investor landscape
$5.5Btotal disclosed funding
65companies funded
100disclosed rounds
0rounds last 90 days
Most active investors
Qiming Venture Partners11 rounds
Sequoia Capital6 rounds
Notable founders
Jielun Zhu
Co-Founder & CFO & CBO · Excalipoint
Lei Fang
Co-Founder & CEO & Chairman · Excalipoint
Tong Zhang
Co-Founder · VelaVigo
Jing LI
Co-Founder & CEO · VelaVigo
Sean Lin
Founder & CEO · ChemLex
Yan Linghua
CEO · Tongshu Biotechnology
Seth Zhang
Co-Founder & CEO · MediTrust Health
Jingye Zhou
Co-Founder & CEO · Eccogene
Datao Liu
Co-Founder · Mabwell
Xin Du
CEO · Mabwell
Indra Santana
CEO · Mojia Biotech
Shizhou Cai
Founder & CEO · Travention
Prism market signals · China · country-scoped Prism corpus, 3,804,260 docs
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
How many Healthcare companies are there in Shanghai, China?
Radar tracks 236 indexable Healthcare companies headquartered in Shanghai, China that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Shanghai, China?
The Healthcare companies in Shanghai, China on this list have raised a combined $5.5B in disclosed equity funding across 65 funded companies.
Which is the highest-funded Healthcare company in Shanghai, China?
MediTrust Health is the highest-funded Healthcare company in Shanghai, China, with $463M in disclosed equity funding.
How many Healthcare companies in Shanghai, China are funded?
65 of the 236 Healthcare companies in Shanghai, China on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Shanghai, China?
None of the Healthcare companies in Shanghai, China on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Shanghai, China Healthcare companies?
The most active investors in Shanghai, China Healthcare companies on this list include Qiming Venture Partners, New Alliance Capital, Spinnotec, Cenova, Legend Capital.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.